Triple-negative breast cancer (TNBC) is a molecular subtype which accounts for approximately 15% of all invasive breast cancers with negative expression of the estrogen receptor (ER), progesterone receptor (PR), and human epithelial growth factor receptor-2 (HER-2) (Bianchini et al., 2016). The gene discussed is ESR1; the disease is triple-negative breast carcinoma.